FDA to review use of Amitiza for IBS

09/19/2007 | CNNMoney

The FDA is considering an additional approval for the chronic constipation drug Amitiza as a treatment for irritable bowel syndrome with constipation in an 8-microgram dose. The agency is expected to issue a decision in the second quarter of 2008.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC